OR WAIT null SECS
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Pharmaceutical Executive
The number of pharmaceuticals in development recently mushroomed, and the complexity of trials is increasing. Amgen has reduced its cycle times but still wants to improve efficiency and cost effectiveness as it enlarges its pipeline, presenting tough new challenges in clinical research.